|
Detailed information for selected cell line:
| Cell Line: |
CA2
|
| NIH Registration Number: |
0138
|
| NIH Approval Number: |
NIHhESC-11-0138
|
| Available for Distribution: |
Yes
|
| Provider Restrictions: |
An MTA must be signed between the requesting investigator and Mount Sinai Hospital, Toronto Canada. A research plan is required and all research must have obtained relevant permissions through the requesting investigator's national regulations. In Canada, research must follow the Stem Cell Oversight Committee guidelines and SCOC approval for the use of the cell lines must be obtained.
|
| Additional Information: |
(None)
|
| NIH Restrictions: |
NIH-funded research with this line may only be conducted at Mount Sinai Hospital and “other Canadian laboratories affiliated with the Canadian Stem Cell Network for further research or potential clinical use."
|
| Submitting Organization: |
Mt Sinai Hosp-Samuel Lunenfeld Research Institute |
| Provider Name: |
Andras Nagy
|
| Provider Phone: |
416 586-4800 x 3246
|
| Provider Email: |
nagy@lunenfeld.ca
|
| Provider URL: |
http://www.mshri.on.ca/nagy/
|
| Approval Date: |
12/12/2011 |
View All Lines Eligible for Use
Go to NIH Form 2890 Login Page
Go to NIH Stem Cell Information Page
| |
NIH Form 2890:
- Login
Page
(Authorization Required)
Contact Us:
- Email questions to:
hescregistry@mail.nih.gov
(Emails that are offensive or unrelated to stem cells will be
deleted.)
|
| |
|
Warning! This browser is not supported - Some features might not work. Try using a different browser such as Chrome, Edge, Firefox, or Safari.
NIH Staff 
